Methods |
RCT |
Participants |
Country: USA N = 60 (30 sevoflurane, 30 desflurane) Sex: female Exclusion: neurologic disease, CVS or metabolic diseases, impaired renal or hepatic function, BW > 100% above the ideal or history of alcohol or drug abuse Operation: laparoscopic tubal ligation Desflurane subgroup (treatment, control) ‐ASA: I/II; 10/5, 11/4 ‐Age: 28±4, 27±6 ‐Duration of anaesthesia:76±20;78±22 min Sevoflurane subgroup (treatment, control) ‐ASA: I/II; 11/4, 10/5 ‐Age: 26±6, 26±7 ‐Duration of anaesthesia: 74±21, 75±21 min |
Interventions |
Desflurane guided by BIS (Rev 3.12U; Model A ‐1050, Aspect Medical Systems, Natick, MA) at value of 60
Desflurane using standard clinical guide
Sevoflurane guided by BIS BIS (Rev3.12U; Model A ‐1050, Aspect Medical Systems, Natick, MA) at value of 60
Sevoflurane using standard clinical guide
|
Outcomes |
‐End tidal concentration (%) ‐Exposure to desflurane (MAC. hrs) ‐Consumption of desflurane (ml) ‐Consumption of mivacurium (mg) ‐Consumption of fentanyl (µg) ‐Time to verbal response (min) ‐Time to extubation (min) ‐Time to orientation (min) ‐Time to PACU stay (min) ‐Time to oral intake (min) ‐Time to home readiness (min) ‐Patients with recall awareness ‐Patients with increased airway pressure ‐Patient with coughing and bucking |
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Low risk |
" Patients were randomly assigned to one of four study groups according to a computer‐generated random numbers table." |
Allocation concealment (selection bias) |
Unclear risk |
The study has not mentioned about the allocation concealment |
Incomplete outcome data (attrition bias) All outcomes |
Low risk |
No missing outcome data |
Selective reporting (reporting bias) |
Low risk |
All expected outcomes were reported |
Other bias |
Unclear risk |
The unblinded anaesthesiologist could potentially lead to 'learning contamination bias' |
Blinding of patients? |
Low risk |
All patients were anaesthetized |
Blinding of anaesthesiologists? |
High risk |
"In the BIS‐titrated groups, the volatile anaesthetics were titrated to maintain a BIS index of 60." This indicates no blinding of anaesthesia care providers |
Blinding of outcome assessors? |
Unclear risk |
The study has not mentioned about outcome assessor blinding |